Submacular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema.

ABSTRACT:

Purpose

In this study, we describe a new surgical technique for the treatment of refractory DME. The technique consists of vitrectomy with ILM peeling with a subretinal injection of ranibizumab.

Methods

This is a prospective interventional noncomparative study including patients with refractory DME. Included patients were subjected to the new surgical technique of pars plana vitrectomy with subretinal injection of ranibizumab.

Results

The study included 19 eyes with refractory macular edema, in which this novel technique was attempted. There were 10 males and 9 females. The age of the patients ranged from 17 to 67 years with a mean of 55.58 ± 13.242 years. The duration of diabetes before enrollment in the study ranged from 7 to 25 years with a mean of 16.3 years. Preo

SUBMITTER: El-Baha SM 

PROVIDER: S-EPMC6854934 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature